Data is generated.
{{heroWord}} is built.
Nobody ever built a product out of a dataset. Metaceutic works both ends of it — designing the experiment before the first sample exists, and staying in the work until there is a lead you can actually build on. The method holds wherever a complex microbial community shapes the outcome.
Three ways in.
The platform is the asset. You can license it, build on it with us, or contract us to build with it. Most engagements begin as one and become another.
{{ way.head }}
{{ way.desc }}
Which one fits is usually clear within a conversation.
What we own.
Four assets, built since 2019. Together they are why our reading of a dataset is faster and more specific than a literature search — and why the answer arrives as a direction rather than a description.
{{ a.title }}
{{ a.body }}
From question to evidence.
Most microbiome engagements begin when the samples arrive and end when the report is delivered. We enter earlier and stay later, because that is where the value is.
{{ step.title }}
{{ step.detail }}
Data generation can be bought anywhere.
The ends are where a programme is won or lost.
Built on this platform.
We have used it ourselves. Twice, from idea to market.
Both were built here and taken from ideation to proof of business. Both are now moving on to organisations equipped to scale them.
That is the model: build it, prove it, hand it to someone who can scale it, and carry the learnings into the next one. Each cycle sharpens the platform. What compounds stays here.
One method, many ecosystems.
The method is not specific to the gut. The biology changes between ecosystems. The question does not: what is in there, what is it doing, and what would change it.
{{ eco.head }}
{{ eco.body }}
Gut is where we proved it. It was never the boundary.
Why complex ecosystems are the leverage point.
Chronic inflammatory conditions — metabolic disease, mental health disorders, immune dysfunction — are difficult to reverse once established, and poorly served by medicine that begins at the symptom.
They are also, increasingly, traceable to microbial ecosystems that are unusually data-rich and unusually modifiable — a system you can read at depth and change deliberately. The shift this enables is from reacting to a condition to intervening before it establishes: a different kind of product, backed by a different kind of evidence.
{{ c.h }}
{{ c.p }}
Assembled for your problem.
Metaceutic does not carry a standing research department, and that is a deliberate choice rather than a constraint.
{{ t.h }}
{{ t.p }}
Start a conversation.
Scope, terms, and whether we are the right partner for a given problem are all settled faster in a conversation than on a page.
partnerships@metaceutic.com ↗Founded on conviction, built on science.
Metaceutic was founded in 2019 on a straightforward proposition: that many of the conditions doing the most damage to human health are rooted in biological systems we have only recently become able to read — and that reading them properly is the precondition for doing anything useful about them.
A decade in pharma, then a different path.
In 2019, after more than a decade seeding and driving innovation at the highest level of the pharmaceutical industry, Ali Kazemi left a senior leadership role to found Metaceutic — motivated by a conviction that the tools existed to address the root causes of a range of global lifestyle epidemics, and that nobody was building them.
From sick-care to health-care.
Metaceutic's focus is not on treating disease once it has established, but on understanding what precedes it. Combining metagenomics with AI-assisted interpretation, the company develops the evidence base that makes earlier and more precise intervention possible in chronic inflammatory conditions.
The conviction is that the future of healthcare lies in genuine prognostics and proactive management rather than late-stage diagnostics and symptomatic treatment — complex microbial ecosystems, among the most data-rich and modifiable systems available to us, sit at the centre of that shift.
What shapes Metaceutic.
{{ pr.h }}
{{ pr.p }}
Start a conversation.
Scope, terms, and whether we are the right partner for a given problem are all settled faster in a conversation than on a page.
partnerships@metaceutic.com ↗